Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | KCNN4 | O15554 | 4/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5571950 | 0.79 | KIF11 (0.43) | KIF11MAPK1KCNN4TSHRALDH1A1 | |
| SCHEMBL29569674 | 0.75 | KIF11 (0.40) | KIF11MAPK1KCNN4TSHRALDH1A1 | |
| SCHEMBL2462425 | 0.75 | MAPK1 (0.42) | KIF11MAPK1KCNN4TSHRALDH1A1 | |
| SCHEMBL1315596 | 0.71 | MAPK1 (0.44) | KIF11MAPK1KCNN4TSHRALDH1A1 | |
| SCHEMBL297786 | 0.69 | MAPK1 (0.52) | KIF11MAPK1KCNN4TSHRALDH1A1 | |
| SCHEMBL8973 | 0.69 | KIF11 (0.48) | KIF11MAPK1KCNN4TSHRALDH1A1 | |
| Ammonia Solution, Strong SCHEMBL23726528 | 0.67 | KIF11 (0.46) | KIF11MAPK1KCNN4TSHRALDH1A1 | |
| Hydrochloric Acid SCHEMBL28556207 | 0.67 | KIF11 (0.46) | KIF11MAPK1KCNN4TSHRALDH1A1 | |
| Bromide SCHEMBL28557682 | 0.67 | KIF11 (0.46) | KIF11MAPK1KCNN4TSHRALDH1A1 | |
| Methoxytriphenylmethane SCHEMBL9103 | 0.65 | MAPK1 (0.48) | KIF11MAPK1KCNN4TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11879052-B2 | Curatives | HEXCEL COMPOSITES LIMITED (GB) | 2024-01-23 | — | — | US | disclosed |
| US-11702516-B2 | Curative composition and a resin composition containing the curative composition | HEXCEL COMPOSITES LIMITED (GB) | 2023-07-18 | — | — | US | disclosed |
| US-20230167272-A1 | IMPROVEMENTS IN OR RELATING TO CURATIVES | HEXCEL COMPOSITES LIMITED (GB) | 2023-06-01 | — | — | US | disclosed |
| US-20200385536-A1 | A CURATIVE COMPOSITION AND A RESIN COMPOSITION CONTAINING THE CURATIVE COMPOSITION | HEXCEL COMPOSITES LIMITED (GB) | 2020-12-10 | — | — | US | disclosed |
| WO-2020216688-A1 | IMPROVEMENTS IN OR RELATING TO CURATIVES | HEXCEL COMPOSITES LIMITED (GB) | 2020-10-29 | — | — | WO | disclosed |
| EP-3728414-A1 | A CURATIVE COMPOSITION AND A RESIN COMPOSITION CONTAINING THE CURATIVE COMPOSITION | Hexcel Composites Limited (GB) | 2020-10-28 | — | — | EP | disclosed |
| US-10123412-B2 | Thermosetting polymer formulations, circuit materials, and methods of use thereof | ROGERS CORPORATION (US) | 2018-11-06 | — | — | US | disclosed |
| US-9790400-B2 | Organic-inorganic complex, and forming composition thereof | NIPPON SODA CO., LTD. (JP) | 2017-10-17 | — | — | US | disclosed |
| US-20170218171-A1 | THERMOSETTING POLYMER FORMULATIONS, CIRCUIT MATERIALS, AND METHODS OF USE THEREOF | JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT | 2017-08-03 | — | — | US | disclosed |
| WO-2017132310-A1 | THERMOSETTING POLYMER FORMULATIONS, CIRCUIT MATERIALS, AND METHODS OF USE THEREOF | ROGERS CORPORATION (US) | 2017-08-03 | — | — | WO | disclosed |
| US-20120004349-A1 | Epoxy resin composition, curing agent, and curing accelerator | NIPPON SODA CO., LTD. | 2012-01-05 | — | — | US | disclosed |
| US-20120004377-A1 | CLATHRATE, CURING AGENT, CURE ACCELERATOR, EPOXY RESIN COMPOSITION, AND EPOXY RESIN COMPOSITION FOR ENCAPSULATION OF SEMICONDUCTOR | NIPPON SODA CO., LTD. | 2012-01-05 | — | — | US | disclosed |
| US-20090093599-A1 | CURATIVES FOR EPOXY RESIN, CURING ACCELERATOR, AND EPOXY RESIN COMPOSITION | NIPPON SODA CO., LTD. (JP) | 2009-04-09 | — | — | US | disclosed |
| US-7495060-B2 | Tetrakisphenol and non-clathrated curing agent for epoxy resin | NIPPON SODA CO., LTD. (JP) | 2009-02-24 | — | — | US | disclosed |
| US-20060287465-A1 | Curatives for epoxy resin, curing accelerator, and epoxy resin composition | NIPPON SODA CO., LTD (JP) | 2006-12-21 | — | — | US | disclosed |
| EP-1520867-A2 | Curatives for epoxy resin, curing accelerator, and epoxy resin composition | NIPPON SODA CO., LTD. (JP) | 2005-04-06 | — | — | EP | disclosed |
| EP-0949286-B1 | CURATIVES FOR EPOXY RESIN, CURING ACCELERATOR, AND EPOXY RESIN COMPOSITION | NIPPON SODA CO (JP) | 2005-03-02 | — | — | EP | disclosed |
| US-20040106764-A1 | Curatives for epoxy resin, curing accelerator, and epoxy resin composition | SUZUKI HIROSHI (JP) | 2004-06-03 | — | — | US | disclosed |
| US-6727325-B1 | HEAT RESISTANCE, STABILITY, POT LIFE; ONE-PACK MIXTURES; LOW TEMPERATURE CURABILITY | NIPPON SODA CO. LTD. (JP) | 2004-04-27 | — | — | US | disclosed |
| EP-0949286-A1 | CURATIVES FOR EPOXY RESIN, CURING ACCELERATOR, AND EPOXY RESIN COMPOSITION | NIPPON SODA CO., LTD. (JP) | 1999-10-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120004377-A1 | CLATHRATE, CURING AGENT, CURE ACCELERATOR, EPOXY RESIN COMPOSITION, AND EPOXY RESIN COMPOSITION FOR ENCAPSULATION OF SEMICONDUCTOR | SEM1, RCC1, BMI1 | KIF11 4363/4885MAPK1 4171/4885KCNN4 3578/4885 |
| US-20120004349-A1 | Epoxy resin composition, curing agent, and curing accelerator | DCTN1, ARCN1, UNC119 | KIF11 2740/4885MAPK1 4059/4885KCNN4 3751/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.